Karyopharm Therapeutics Inc (KPTI)
0.858
+0.08
(+10.34%)
USD |
NASDAQ |
Nov 22, 12:41
Karyopharm Therapeutics Shareholders Equity (Quarterly): -159.65M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -159.65M |
| June 30, 2024 | -132.14M |
| March 31, 2024 | -168.96M |
| December 31, 2023 | -136.21M |
| September 30, 2023 | -100.40M |
| June 30, 2023 | -71.25M |
| March 31, 2023 | -45.17M |
| December 31, 2022 | -16.66M |
| September 30, 2022 | -140.28M |
| June 30, 2022 | -116.34M |
| March 31, 2022 | -83.08M |
| December 31, 2021 | -79.67M |
| September 30, 2021 | -125.98M |
| June 30, 2021 | -83.13M |
| March 31, 2021 | -39.64M |
| December 31, 2020 | 50.55M |
| September 30, 2020 | 83.77M |
| June 30, 2020 | 129.80M |
| March 31, 2020 | 166.15M |
| December 31, 2019 | 49.77M |
| September 30, 2019 | 59.87M |
| June 30, 2019 | 82.47M |
| March 31, 2019 | 121.28M |
| December 31, 2018 | 183.17M |
| Date | Value |
|---|---|
| September 30, 2018 | 171.08M |
| June 30, 2018 | 213.47M |
| March 31, 2018 | 95.53M |
| December 31, 2017 | 129.46M |
| September 30, 2017 | 141.18M |
| June 30, 2017 | 166.71M |
| March 31, 2017 | 138.36M |
| December 31, 2016 | 162.24M |
| September 30, 2016 | 166.93M |
| June 30, 2016 | 153.57M |
| March 31, 2016 | 177.04M |
| December 31, 2015 | 198.36M |
| September 30, 2015 | 220.59M |
| June 30, 2015 | 247.33M |
| March 31, 2015 | 275.52M |
| December 31, 2014 | 206.79M |
| September 30, 2014 | 227.80M |
| June 30, 2014 | 131.68M |
| March 31, 2014 | 144.10M |
| December 31, 2013 | 154.93M |
| September 30, 2013 | -47.78M |
| June 30, 2013 | 59.94M |
| December 31, 2012 | -27.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-168.96M
Minimum
Mar 2024
166.15M
Maximum
Mar 2020
-50.93M
Average
-81.38M
Median
Shareholders Equity (Quarterly) Benchmarks
| Bruker Corp | 1.807B |
| Ionis Pharmaceuticals Inc | 662.47M |
| Apellis Pharmaceuticals Inc | 237.12M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 189.48M |
| Total Liabilities (Quarterly) | 349.12M |
| Debt to Equity Ratio | -1.194 |
| Current Ratio | 3.004 |
| Net Debt Paydown Yield | -3.86% |